HUSCAP logo Hokkaido Univ. logo

Hokkaido University Collection of Scholarly and Academic Papers >

Sort by: In order: Results/Page Authors/Record:
Export metadata:
Showing results 1 to 7 of 7
TypeAuthor(s)TitleOther TitlesCitationCitation(alt)Issue Date
articleYasuyuki, Kawamoto; Satoshi, Yuki; Kentaro, Sawada; Tsuji, Yasushi; Dazai, Masayoshi; Okuda, Hiroyuki; Meguro, Takashi; Harada, Kazuaki; Sekiguchi, Mari; Okada, Kazufumi; Ito, Yoichi M.; Sakata, Yuh; Sakamoto, Naoya; Komatsu, YoshitoPhase II Study of Ramucirumab Plus Irinotecan Combination Therapy as Second-Line Treatment in Patients with Advanced Gastric Cancer : HGCSG1603-The Oncologist-Aug-2022
articleKen, Ito; Satoshi, Yuki; Hiroshi, Nakatsumi; Kawamoto, Yasuyuki; Harada, Kazuaki; Nakano, Shintaro; Saito, Rika; Ando, Takayuki; Sawada, Kentaro; Yagisawa, Masataka; Ishiguro, Atsushi; Dazai, Masayoshi; Iwanaga, Ichiro; Hatanaka, Kazuteru; Sato, Atsushi; Matsumoto, Ryusuke; Shindo, Yoshiaki; Tateyama, Miki; Muranaka, Tetsuhito; Katagiri, Masaki; Yokota, Isao; Sakata, Yuh; Sakamoto, Naoya; Komatsu, YoshitoMulticenter, prospective, observational study of chemotherapy-induced dysgeusia in gastrointestinal cancer-Supportive Care in Cancer-1-Jun-2022
articleYasuyuki, Kawamoto; Satoshi, Yuki; Takashi, Meguro; Hatanaka, Kazuteru; Uebayashi, Minoru; Nakamura, Michio; Okuda, Hiroyuki; Iwanaga, Ichiro; Kato, Takashi; Nakano, Shintaro; Sato, Atsushi; Harada, Kazuaki; Oba, Koji; Sakata, Yuh; Sakamoto, Naoya; Komatsu, YoshitoPhase II Study of Continued Trastuzumab Plus Irinotecan in Patients with HER2-positive Gastric Cancer Previously Treated with Trastuzumab (HGCSG 1201)-The Oncologist-May-2022
articleNakano, Shintaro; Kawamoto, Yasuyuki; Yuki, Satoshi; Harada, Kazuaki; Miyagishima, Takuto; Sogabe, Susumu; Dazai, Masayoshi; Sato, Atsushi; Ishiguro, Atsushi; Nakamura, Michio; Kajiura, Shinya; Takahashi, Yasuo; Tateyama, Miki; Hatanaka, Kazuteru; Tsuji, Yasushi; Sasaki, Takahide; Shindo, Yoshiaki; Kobayashi, Tomoe; Yokota, Isao; Sakamoto, Naoya; Sakata, Yuh; Komatsu, YoshitoStudy protocol of the HGCSG1803 : a phase II multicentre, non-randomised, single-arm, prospective trial of combination chemotherapy with oxaliplatin, irinotecan and S-1 (OX-IRIS) as first-line treatment for metastatic or relapsed pancreatic cancer-BMJ Open-May-2022
articleKawamoto, Yasuyuki; Komatsu, Yoshito; Yuki, Satoshi; Sawada, Kentaro; Muranaka, Tetsuhito; Harada, Kazuaki; Nakatsumi, Hiroshi; Fukushima, Hiraku; Ishiguro, Atsushi; Dazai, Masayoshi; Hatanaka, Kazuteru; Nakamura, Michio; Iwanaga, Ichiro; Uebayashi, Minoru; Sogabe, Susumu; Kobayashi, Yoshimitsu; Miyagishima, Takuto; Ono, Kota; Sakamoto, Naoya; Sakata, YuhStudy protocol of HGCSG1404 SNOW study : a phase I/II trial of combined chemotherapy of S-1, nab-paclitaxel and oxaliplatin administered biweekly to patients with advanced gastric cancer-BMC cancer-8-Dec-2017
article (author version)Komatsu, Yoshito; Yuki, Satoshi; Sogabe, Susumu; Fukushima, Hiraku; Nakatsumi, Hiroshi; Kobayashi, Yoshimitsu; Iwanaga, Ichiro; Nakamura, Michio; Hatanaka, Kazuteru; Miyagishima, Takuto; Kudo, Mineo; Munakata, Masaki; Meguro, Takashi; Tateyama, Miki; Sakata, YuhPhase II study of combined chemotherapy with irinotecan and S-1 (IRIS) plus bevacizumab in patients with inoperable recurrent or advanced colorectal cancer-Acta Oncologica-Sep-2012
article (author version)Komatsu, Yoshito; Takahashi, Yutaka; Kimura, Yutaka; Oda, Hisashi; Tajima, Yusuke; Tamura, Shigeyuki; Sakurai, Jo; Wakasugi, Takehiro; Tatebe, Shigeru; Takahashi, Masahiro; Sakata, Yuh; Kitajima, Masaki; Sakamoto, Junichi; Saji, ShigetoyoRandomized phase II trial of first-line treatment with tailored irinotecan and S-1 therapy versus S-1 monotherapy for advanced or recurrent gastric carcinoma (JFMC31-0301)-Anti-Cancer Drugs-Jul-2011
Showing results 1 to 7 of 7

 

Hokkaido University